Paclitaxel in Treating Patients With Early-Stage Bladder Cancer

NCT00002917 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: paclitaxel

Sponsor

Mary Babb Randolph Cancer Center at West Virginia University Hospitals